Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.2 |
mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.11 | 0.2 |
mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.099 | 0.2 |
mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |